86816 Hla typing dr/dq
Also known as: HLA class II serology, HLA DR/DQ typing
Human leukocyte antigen class II typing for HLA-DR and HLA-DQ molecules performed using serologic methodology. Initial typing for transplant evaluation.
In Plain Language
Immune system type test; Transplant compatibility test
Clinical Context
Used in transplant evaluation, disease association studies, and autoimmune disease workup. HLA-DR and HLA-DQ are important immunologic molecules.
RVU Information
CPT 86816 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 86816?
CPT 86816 (Hla typing dr/dq) is a Pathology & Lab code. Human leukocyte antigen class II typing for HLA-DR and HLA-DQ molecules performed using serologic methodology. Initial typing for transplant evaluation.
Who uses CPT code 86816?
CPT 86816 is used by Pathology, Immunology, Transplantation. Used in transplant evaluation, disease association studies, and autoimmune disease workup. HLA-DR and HLA-DQ are important immunologic molecules.
When is CPT 86816 used?
Used in transplant evaluation, disease association studies, and autoimmune disease workup. HLA-DR and HLA-DQ are important immunologic molecules.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.